₹61.00
NSE close, 16 Nov 2026
−36.16%
SHEEL BIOTECH is a small cap company, listed on NSE SME under the symbol SHEEL. At ₹61.00 a share, the market values the whole company at ₹124 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹110 crore and a net profit of ₹12 crore, an operating margin of 14.8%.
The market values the company at 8.3 times its profit over the last twelve months and 0.95 times its book value; its return on equity is 11.5% and its borrowings are 0.15 times its equity.
Promoters hold 72.31% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 9.66%.
Over the past year the share price has fallen 19.7%, and it is 24.7% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | 6M to Sep 2025 | 6M to Mar 2026 | 6M to Sep 2026 |
|---|---|---|---|
| Sales | 21.9 | 88.2 | 50.6 |
| Expenses | 20.1 | 73.7 | 45.0 |
| Operating profit | 1.8 | 14.5 | 5.6 |
| Operating margin | 8.1% | 16.5% | 11.0% |
| Other income | 0.2 | 0.6 |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Monitoring Agency Report for the Half year ended on 30th September, 2026.
Receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production.
| 0.3 |
| Interest | 1.2 | 0.8 | 1.3 |
|---|
| Depreciation | 0.5 | 0.6 | 0.5 |
|---|
| Profit before tax | 0.3 | 13.8 | 4.1 |
|---|
| Tax | 0.1 | 2.2 | 0.7 |
|---|
| Net profit | 0.2 | 11.6 | 3.4 |
|---|
| EPS (₹) | 0.13 | 6.69 | 1.66 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 110 |
| Expenses | 93.7 |
| Operating profit | 16.3 |
| Operating margin | 14.8% |
| Other income | 0.7 |
| Interest | 1.9 |
| Depreciation | 1.1 |
| Profit before tax | 14.0 |
| Tax | 2.3 |
| Net profit | 11.8 |
| EPS (₹) | 6.69 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | −17.6 | −5.3 |
| From investing | −6.6 | −6.3 |
| From financing | 25.9 | 9.6 |
| Spent on fixed assets | −6.7 | −7.1 |
| Free cash flow | −24.2 | −12.3 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 10.7% |
| Operating margin | 14.8% |
| Return on equity | 9.3% |
| Return on capital employed | 11.7% |
| Return on assets | 8.1% |
| Debt to equity | 0.07 |
| Interest coverage | 8.30 |
| Debt to assets | 0.06 |
| Current ratio | 7.53 |
| Quick ratio | 5.79 |
| Cash ratio | 0.01 |
| Asset turnover | 0.75 |
| Fixed asset turnover | 11.62 |
| Inventory turnover | 2.30 |
| Receivables turnover | 1.80 |
| Gross margin | 38.2% |
| Cash from operations to profit | -149.0% |
| Effective tax rate | 16.1% |
Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026.
Has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026
Award of Work having contract value of Rs. 4.54 Crore from the Department of Agriculture, Government of Himachal Pradesh, for establishment of Demonstration Blueberry Farm and Blueberry Tissue Culture Laboratory
Voting results of Annual General Meeting held on September 24, 2026
A copy Srutinizers report of Annual General Meeting held on September 24, 2026
Proceedings of Annual General Meeting held on September 24, 2026
As General Updates regarding the Change in Name of the Statutory Auditor firm of the Company
The finalisation of Commercial Transactions for Blueberry Project amounting to INR 14.53 Crores.
Regarding Record Date & Book Closure for the purpose of 35th Annual General Meeting
. Clarification on the monitoring agency report